NASDAQ: LFWD
Lifeward Ltd Stock Forecast, Predictions & Price Target

Analyst price target for LFWD

Based on 1 analyst offering 12 month price targets for Lifeward Ltd

Min Forecast
$13.00+733.33%
Avg Forecast
$13.00+733.33%
Max Forecast
$13.00+733.33%

Should I buy or sell LFWD stock?

Based on 1 analyst offering ratings for Lifeward Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LFWD's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates LFWD as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their LFWD stock forecasts and price targets.

LFWD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-13

1 of 1

Forecast return on equity

Is LFWD forecast to generate an efficient return?

Company
61.07%
Industry
-9.64%
Market
63.8%
LFWD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LFWD forecast to generate an efficient return on assets?

Company
45.22%
Industry
14.07%
LFWD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LFWD earnings per share forecast

What is LFWD's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.16
Avg 2 year Forecast
$0.88
Avg 3 year Forecast
$1.72

LFWD revenue forecast

What is LFWD's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$41.3M+65.19%
Avg 2 year Forecast
$70.2M+180.62%
Avg 3 year Forecast
$107.9M+331.57%
LFWD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LFWD revenue growth forecast

How is LFWD forecast to perform vs Medical Devices companies and vs the US market?

Company
62.06%
Industry
9.19%
Market
11.67%
LFWD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LFWD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LFWD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
LFWD$1.56$13.00+733.33%Buy
ADGM$0.89N/AN/A
SSKN$2.95N/AN/A
QTI$0.48N/AN/A
AEMD$0.64$7.00+1,002.36%Buy

Lifeward Stock Forecast FAQ

Is Lifeward Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: LFWD) stock is to Buy LFWD stock.

Out of 1 analyst, 0 (0%) are recommending LFWD as a Strong Buy, 1 (100%) are recommending LFWD as a Buy, 0 (0%) are recommending LFWD as a Hold, 0 (0%) are recommending LFWD as a Sell, and 0 (0%) are recommending LFWD as a Strong Sell.

If you're new to stock investing, here's how to buy Lifeward stock.

What is LFWD's earnings growth forecast for 2025-2027?

(NASDAQ: LFWD) Lifeward's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 25.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.16%.

Lifeward's earnings in 2025 is -$19,303,000.On average, 1 Wall Street analyst forecast LFWD's earnings for 2025 to be -$1,409,303, with the lowest LFWD earnings forecast at -$1,409,303, and the highest LFWD earnings forecast at -$1,409,303. On average, 1 Wall Street analyst forecast LFWD's earnings for 2026 to be $7,751,166, with the lowest LFWD earnings forecast at $7,751,166, and the highest LFWD earnings forecast at $7,751,166.

In 2027, LFWD is forecast to generate $15,150,006 in earnings, with the lowest earnings forecast at $15,150,006 and the highest earnings forecast at $15,150,006.

What is LFWD's revenue growth forecast for 2025-2027?

(NASDAQ: LFWD) Lifeward's forecast annual revenue growth rate of 62.06% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.19%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.67%.

Lifeward's revenue in 2025 is $25,002,000.On average, 1 Wall Street analysts forecast LFWD's revenue for 2025 to be $363,776,306, with the lowest LFWD revenue forecast at $363,776,306, and the highest LFWD revenue forecast at $363,776,306. On average, 1 Wall Street analysts forecast LFWD's revenue for 2026 to be $617,979,313, with the lowest LFWD revenue forecast at $617,979,313, and the highest LFWD revenue forecast at $617,979,313.

In 2027, LFWD is forecast to generate $950,398,630 in revenue, with the lowest revenue forecast at $950,398,630 and the highest revenue forecast at $950,398,630.

What is LFWD's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: LFWD) forecast ROA is 45.22%, which is higher than the forecast US Medical Devices industry average of 14.07%.

What is LFWD's Price Target?

According to 1 Wall Street analyst that have issued a 1 year LFWD price target, the average LFWD price target is $13.00, with the highest LFWD stock price forecast at $13.00 and the lowest LFWD stock price forecast at $13.00.

The Wall Street analyst predicted that Lifeward's share price could reach $13.00 by Nov 13, 2025. The average Lifeward stock price prediction forecasts a potential upside of 733.33% from the current LFWD share price of $1.56.

What is LFWD's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: LFWD) Lifeward's current Earnings Per Share (EPS) is -$2.21. On average, analysts forecast that LFWD's EPS will be -$0.16 for 2025, with the lowest EPS forecast at -$0.16, and the highest EPS forecast at -$0.16. On average, analysts forecast that LFWD's EPS will be $0.88 for 2026, with the lowest EPS forecast at $0.88, and the highest EPS forecast at $0.88. In 2027, LFWD's EPS is forecast to hit $1.72 (min: $1.72, max: $1.72).

What is LFWD's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: LFWD) forecast ROE is 61.07%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.